MXPA03004195A - Combination therapy for estrogen-dependent disorders. - Google Patents

Combination therapy for estrogen-dependent disorders.

Info

Publication number: MXPA03004195A
Authority: MX; Mexico
Prior art keywords: estrogen; combination therapy; dependent disorders; disorders; dependent
Prior art date: 2000-11-16

Application number

MXPA03004195A

Other languages

Spanish (es)

Inventor

Dinesh Purandare

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-16

Filing date

2001-11-06

Publication date

2003-09-22

2001-11-06 Application filed by Upjohn Co filed Critical Upjohn Co

2003-09-22 Publication of MXPA03004195A publication Critical patent/MXPA03004195A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MXPA03004195A 2000-11-16 2001-11-06 Combination therapy for estrogen-dependent disorders. MXPA03004195A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71460500A	2000-11-16	2000-11-16
PCT/US2001/043847 WO2002039995A2 (en)	2000-11-16	2001-11-06	Combination therapy for estrogen-dependent disorders

Publications (1)

Publication Number	Publication Date
MXPA03004195A true MXPA03004195A (en)	2003-09-22

Family

ID=24870727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03004195A MXPA03004195A (en)	2000-11-16	2001-11-06	Combination therapy for estrogen-dependent disorders.

Country Status (16)

Country	Link
EP (1)	EP1341549A2 (en)
JP (1)	JP2004536022A (en)
KR (1)	KR20030051828A (en)
CN (1)	CN1498112A (en)
AU (1)	AU2002230464A1 (en)
BR (1)	BR0115423A (en)
CA (1)	CA2428249A1 (en)
CZ (1)	CZ20031349A3 (en)
EA (1)	EA200300572A1 (en)
IL (1)	IL155817A0 (en)
MX (1)	MXPA03004195A (en)
NO (1)	NO20032206L (en)
NZ (1)	NZ525720A (en)
PL (1)	PL365904A1 (en)
WO (1)	WO2002039995A2 (en)
ZA (1)	ZA200303669B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001275210B2 (en)	2000-06-02	2006-09-28	Board Of Regents, The University Of Texas System	Ethylenedicysteine (EC)-drug conjugates
US9050378B2 (en)	2003-12-10	2015-06-09	Board Of Regents, The University Of Texas System	N2S2 chelate-targeting ligand conjugates
GB0506759D0 (en) *	2005-04-02	2005-05-11	Medical Res Council	Combination treatment methods
EP1891964A1 (en) *	2006-08-08	2008-02-27	AEterna Zentaris GmbH	Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
US10925977B2 (en)	2006-10-05	2021-02-23	Ceil>Point, LLC	Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
EP2148682A1 (en) *	2007-04-23	2010-02-03	Bayer Schering Pharma Aktiengesellschaft	Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
CN101775054B (en) *	2010-02-05	2012-12-26	常州佳尔科药业集团有限公司	Synthesis method of 4-hydroxyl-4-alkene-3-ketone steroide compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9911582D0 (en) *	1999-05-18	1999-07-21	Pharmacia & Upjohn Spa	Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
GB9930839D0 (en) *	1999-12-30	2000-02-16	Pharmacia & Upjohn Spa	Process for treating gynecomastia

2001
- 2001-11-06 EA EA200300572A patent/EA200300572A1/en unknown
- 2001-11-06 WO PCT/US2001/043847 patent/WO2002039995A2/en not_active Ceased
- 2001-11-06 CN CNA018189385A patent/CN1498112A/en active Pending
- 2001-11-06 MX MXPA03004195A patent/MXPA03004195A/en unknown
- 2001-11-06 IL IL15581701A patent/IL155817A0/en unknown
- 2001-11-06 AU AU2002230464A patent/AU2002230464A1/en not_active Abandoned
- 2001-11-06 KR KR10-2003-7006608A patent/KR20030051828A/en not_active Withdrawn
- 2001-11-06 BR BR0115423-0A patent/BR0115423A/en not_active IP Right Cessation
- 2001-11-06 EP EP01990699A patent/EP1341549A2/en not_active Withdrawn
- 2001-11-06 CA CA002428249A patent/CA2428249A1/en not_active Abandoned
- 2001-11-06 PL PL01365904A patent/PL365904A1/en not_active Application Discontinuation
- 2001-11-06 CZ CZ20031349A patent/CZ20031349A3/en unknown
- 2001-11-06 JP JP2002542370A patent/JP2004536022A/en active Pending
- 2001-11-06 NZ NZ525720A patent/NZ525720A/en unknown
2003
- 2003-05-13 ZA ZA200303669A patent/ZA200303669B/en unknown
- 2003-05-15 NO NO20032206A patent/NO20032206L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ20031349A3 (en)	2004-05-12
AU2002230464A1 (en)	2002-05-27
ZA200303669B (en)	2004-05-13
CA2428249A1 (en)	2002-05-23
BR0115423A (en)	2005-12-13
NZ525720A (en)	2006-12-22
JP2004536022A (en)	2004-12-02
PL365904A1 (en)	2005-01-10
WO2002039995A3 (en)	2003-05-01
NO20032206L (en)	2003-07-15
IL155817A0 (en)	2003-12-23
KR20030051828A (en)	2003-06-25
WO2002039995A9 (en)	2003-02-06
NO20032206D0 (en)	2003-05-15
EA200300572A1 (en)	2004-06-24
EP1341549A2 (en)	2003-09-10
CN1498112A (en)	2004-05-19
WO2002039995A2 (en)	2002-05-23

Publication	Publication Date	Title
MXPA03001419A (en)	2003-06-06	Therapeutic combination.
GB0009606D0 (en)	2000-06-07	Therapeutic combinations
GB0028429D0 (en)	2001-01-10	Therapy
GB0012671D0 (en)	2000-07-19	Therapeutic agents
GB0003397D0 (en)	2000-04-05	Therapeutic agents
GB0004003D0 (en)	2000-04-12	Therapeutic agents
ZA200202542B (en)	2003-09-23	Treating sleep disorders using desloratadine.
MXPA03003599A (en)	2003-08-01	Antiinflammation agents.
GB0126879D0 (en)	2002-01-02	Combination therapy
GB0005789D0 (en)	2000-05-03	Therapeutic agents
GB0007907D0 (en)	2000-05-17	Therapeutic agents
GB0012214D0 (en)	2000-07-12	Therapeutic agents
GB0008696D0 (en)	2000-05-31	Therapeutic agents
GB0000564D0 (en)	2000-03-01	Therapeutic agents
AU4498201A (en)	2001-10-15	Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
MXPA03004195A (en)	2003-09-22	Combination therapy for estrogen-dependent disorders.
GB0108485D0 (en)	2001-05-23	Combination therapy
GB0007376D0 (en)	2000-05-17	Therapeutic agents
MXPA03001472A (en)	2003-06-06	Compounds for the treatment of addictive disorders.
ZA200110046B (en)	2003-03-06	Therapeutic agents.
HU0200253D0 (en)	2002-03-28	Combination therapy
GB0007740D0 (en)	2000-05-17	Combination therapy
GB0013927D0 (en)	2000-08-02	Combination therapy
GB0014133D0 (en)	2000-08-02	Combination therapy
GB0014135D0 (en)	2000-08-02	Combination therapy